{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:48:59Z","timestamp":1792802939844,"version":"4.5.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL-125436"],"award-info":[{"award-number":["R01-HL-125436"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10741-019-09792-3","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T04:29:52Z","timestamp":1554956992000},"page":"725-741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure"],"prefix":"10.1007","volume":"24","author":[{"given":"Rachel A.","family":"Minerath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane D.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8950-742X","authenticated-orcid":false,"given":"Chad E.","family":"Grueter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,11]]},"reference":[{"issue":"20","key":"9792_CR1","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41388-018-0150-2","volume":"37","author":"D Gerlach","year":"2018","unstructured":"Gerlach D, Tontsch-Grunt U, Baum A, Popow J, Scharn D, Hofmann MH, Engelhardt H, Kaya O, Beck J, Schweifer N, Gerstberger T, Zuber J, Savarese F, Kraut N (2018) The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML. Oncogene 37(20):2687\u20132701. \nhttps:\/\/doi.org\/10.1038\/s41388-018-0150-2","journal-title":"Oncogene"},{"issue":"1","key":"9792_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/JCI62839","volume":"123","author":"JH van Berlo","year":"2013","unstructured":"van Berlo JH, Maillet M, Molkentin JD (2013) Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest 123(1):37\u201345. \nhttps:\/\/doi.org\/10.1172\/JCI62839","journal-title":"J Clin Invest"},{"key":"9792_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1749-6632.2009.05100.x","volume":"1188","author":"H Taegtmeyer","year":"2010","unstructured":"Taegtmeyer H, Sen S, Vela D (2010) Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann N Y Acad Sci 1188:191\u2013198. \nhttps:\/\/doi.org\/10.1111\/j.1749-6632.2009.05100.x","journal-title":"Ann N Y Acad Sci"},{"issue":"50","key":"9792_CR4","doi-asserted-by":"publisher","first-page":"20164","DOI":"10.1073\/pnas.1315155110","volume":"110","author":"R Papait","year":"2013","unstructured":"Papait R, Cattaneo P, Kunderfranco P, Greco C, Carullo P, Guffanti A, Vigano V, Stirparo GG, Latronico MV, Hasenfuss G, Chen J, Condorelli G (2013) Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy. Proc Natl Acad Sci U S A 110(50):20164\u201320169. \nhttps:\/\/doi.org\/10.1073\/pnas.1315155110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9792_CR5","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1074\/jbc.M112.429449","volume":"288","author":"D Sayed","year":"2013","unstructured":"Sayed D, He M, Yang Z, Lin L, Abdellatif M (2013) Transcriptional regulation patterns revealed by high resolution chromatin immunoprecipitation during cardiac hypertrophy. J Biol Chem 288(4):2546\u20132558. \nhttps:\/\/doi.org\/10.1074\/jbc.M112.429449","journal-title":"J Biol Chem"},{"key":"9792_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.yjmcc.2013.07.017","volume":"63","author":"JI Spiltoir","year":"2013","unstructured":"Spiltoir JI, Stratton MS, Cavasin MA, Demos-Davies K, Reid BG, Qi J, Bradner JE, McKinsey TA (2013) BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. J Mol Cell Cardiol 63:175\u2013179. \nhttps:\/\/doi.org\/10.1016\/j.yjmcc.2013.07.017","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"9792_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","volume":"154","author":"P Anand","year":"2013","unstructured":"Anand P, Brown JD, Lin CY, Qi J, Zhang R, Artero PC, Alaiti MA, Bullard J, Alazem K, Margulies KB, Cappola TP, Lemieux M, Plutzky J, Bradner JE, Haldar SM (2013) BET bromodomains mediate transcriptional pause release in heart failure. Cell 154(3):569\u2013582. \nhttps:\/\/doi.org\/10.1016\/j.cell.2013.07.013","journal-title":"Cell"},{"key":"9792_CR8","doi-asserted-by":"publisher","unstructured":"Duan Q, McMahon S, Anand P, Shah H, Thomas S, Salunga HT, Huang Y, Zhang R, Sahadevan A, Lemieux ME, Brown JD, Srivastava D, Bradner JE, McKinsey TA, Haldar SM (2017) BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure. Sci Transl Med 9(390). \nhttps:\/\/doi.org\/10.1126\/scitranslmed.aah5084","DOI":"10.1126\/scitranslmed.aah5084"},{"key":"9792_CR9","doi-asserted-by":"publisher","unstructured":"Sun Y, Xie Y, Du L, Sun J, Liu Z (2018) Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF-kappaB pathway in a rat model of myocardial infarction. Cardiovasc Ther 36 (2). doi:\nhttps:\/\/doi.org\/10.1111\/1755-5922.12320","DOI":"10.1111\/1755-5922.12320"},{"issue":"11","key":"9792_CR10","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/nm778","volume":"8","author":"M Sano","year":"2002","unstructured":"Sano M, Abdellatif M, Oh H, Xie M, Bagella L, Giordano A, Michael LH, DeMayo FJ, Schneider MD (2002) Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat Med 8(11):1310\u20131317. \nhttps:\/\/doi.org\/10.1038\/nm778","journal-title":"Nat Med"},{"issue":"1","key":"9792_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","volume":"113","author":"HJ Kee","year":"2006","unstructured":"Kee HJ, Sohn IS, Nam KI, Park JE, Qian YR, Yin Z, Ahn Y, Jeong MH, Bang YJ, Kim N, Kim JK, Kim KK, Epstein JA, Kook H (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113(1):51\u201359. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.559724","journal-title":"Circulation"},{"issue":"6","key":"9792_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1172\/JCI19137","volume":"112","author":"H Kook","year":"2003","unstructured":"Kook H, Lepore JJ, Gitler AD, Lu MM, Wing-Man Yung W, Mackay J, Zhou R, Ferrari V, Gruber P, Epstein JA (2003) Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112(6):863\u2013871. \nhttps:\/\/doi.org\/10.1172\/JCI19137","journal-title":"J Clin Invest"},{"issue":"22","key":"9792_CR13","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","volume":"113","author":"Y Kong","year":"2006","unstructured":"Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113(22):2579\u20132588. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.625467","journal-title":"Circulation"},{"issue":"3","key":"9792_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/cvr\/cvn215","volume":"80","author":"P Gallo","year":"2008","unstructured":"Gallo P, Latronico MV, Gallo P, Grimaldi S, Borgia F, Todaro M, Jones P, Gallinari P, De Francesco R, Ciliberto G, Steinkuhler C, Esposito G, Condorelli G (2008) Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc Res 80(3):416\u2013424. \nhttps:\/\/doi.org\/10.1093\/cvr\/cvn215","journal-title":"Cardiovasc Res"},{"issue":"10","key":"9792_CR15","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1096\/fj.08-108548","volume":"22","author":"A Granger","year":"2008","unstructured":"Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T, Epstein JA, Gruber PJ (2008) Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 22(10):3549\u20133560. \nhttps:\/\/doi.org\/10.1096\/fj.08-108548","journal-title":"FASEB J"},{"issue":"2","key":"9792_CR16","doi-asserted-by":"publisher","first-page":"H968","DOI":"10.1152\/ajpheart.00891.2006","volume":"293","author":"TM Lee","year":"2007","unstructured":"Lee TM, Lin MS, Chang NC (2007) Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am J Physiol Heart Circ Physiol 293(2):H968\u2013H977. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00891.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"9792_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cardiores.2007.08.010","volume":"76","author":"TC Zhao","year":"2007","unstructured":"Zhao TC, Cheng G, Zhang LX, Tseng YT, Padbury JF (2007) Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res 76(3):473\u2013481. \nhttps:\/\/doi.org\/10.1016\/j.cardiores.2007.08.010","journal-title":"Cardiovasc Res"},{"issue":"7414","key":"9792_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"Consortium EP","year":"2012","unstructured":"Consortium EP (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414):57\u201374. \nhttps:\/\/doi.org\/10.1038\/nature11247","journal-title":"Nature"},{"issue":"7414","key":"9792_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11279","volume":"489","author":"A Sanyal","year":"2012","unstructured":"Sanyal A, Lajoie BR, Jain G, Dekker J (2012) The long-range interaction landscape of gene promoters. Nature 489(7414):109\u2013113. \nhttps:\/\/doi.org\/10.1038\/nature11279","journal-title":"Nature"},{"issue":"14","key":"9792_CR20","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/hmg\/ddg180","volume":"12","author":"LA Lettice","year":"2003","unstructured":"Lettice LA, Heaney SJ, Purdie LA, Li L, de Beer P, Oostra BA, Goode D, Elgar G, Hill RE, de Graaff E (2003) A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet 12(14):1725\u20131735","journal-title":"Hum Mol Genet"},{"issue":"5644","key":"9792_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.1088328","volume":"302","author":"MA Nobrega","year":"2003","unstructured":"Nobrega MA, Ovcharenko I, Afzal V, Rubin EM (2003) Scanning human gene deserts for long-range enhancers. Science 302(5644):413. \nhttps:\/\/doi.org\/10.1126\/science.1088328","journal-title":"Science"},{"issue":"2","key":"9792_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA (2013) Master transcription factors and Mediator establish super-enhancers at key cell identity genes. Cell 153(2):307\u2013319. \nhttps:\/\/doi.org\/10.1016\/j.cell.2013.03.035","journal-title":"Cell"},{"issue":"2","key":"9792_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.sbi.2007.12.002","volume":"18","author":"D Panne","year":"2008","unstructured":"Panne D (2008) The enhanceosome. Curr Opin Struct Biol 18(2):236\u2013242. \nhttps:\/\/doi.org\/10.1016\/j.sbi.2007.12.002","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"9792_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0092-8674(00)80893-4","volume":"92","author":"M Carey","year":"1998","unstructured":"Carey M (1998) The enhanceosome and transcriptional synergy. Cell 92(1):5\u20138","journal-title":"Cell"},{"issue":"14","key":"9792_CR25","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1073\/pnas.1016959108","volume":"108","author":"A He","year":"2011","unstructured":"He A, Kong SW, Ma Q, Pu WT (2011) Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci U S A 108(14):5632\u20135637. \nhttps:\/\/doi.org\/10.1073\/pnas.1016959108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9792_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.14348\/molcells.2018.2297","volume":"41","author":"HY Shin","year":"2018","unstructured":"Shin HY (2018) Targeting super-enhancers for disease treatment and diagnosis. Mol Cell 41(6):506\u2013514. \nhttps:\/\/doi.org\/10.14348\/molcells.2018.2297","journal-title":"Mol Cell"},{"issue":"7 Pt B","key":"9792_CR27","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.bbamcr.2015.11.026","volume":"1863","author":"S Ounzain","year":"2016","unstructured":"Ounzain S, Pedrazzini T (2016) Super-enhancer lncs to cardiovascular development and disease. Biochim Biophys Acta 1863(7 Pt B):1953\u20131960. \nhttps:\/\/doi.org\/10.1016\/j.bbamcr.2015.11.026","journal-title":"Biochim Biophys Acta"},{"issue":"50","key":"9792_CR28","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107(50):21931\u201321936. \nhttps:\/\/doi.org\/10.1073\/pnas.1016071107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7153","key":"9792_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature06008","volume":"448","author":"TS Mikkelsen","year":"2007","unstructured":"Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O\u2019Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448(7153):553\u2013560. \nhttps:\/\/doi.org\/10.1038\/nature06008","journal-title":"Nature"},{"issue":"1","key":"9792_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2007.05.042","volume":"130","author":"MG Guenther","year":"2007","unstructured":"Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA (2007) A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130(1):77\u201388. \nhttps:\/\/doi.org\/10.1016\/j.cell.2007.05.042","journal-title":"Cell"},{"issue":"2","key":"9792_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2005.01.001","volume":"120","author":"BE Bernstein","year":"2005","unstructured":"Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas EJ 3rd, Gingeras TR, Schreiber SL, Lander ES (2005) Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120(2):169\u2013181. \nhttps:\/\/doi.org\/10.1016\/j.cell.2005.01.001","journal-title":"Cell"},{"issue":"3","key":"9792_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ng1966","volume":"39","author":"ND Heintzman","year":"2007","unstructured":"Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39(3):311\u2013318. \nhttps:\/\/doi.org\/10.1038\/ng1966","journal-title":"Nat Genet"},{"issue":"7345","key":"9792_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature09906","volume":"473","author":"J Ernst","year":"2011","unstructured":"Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE (2011) Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473(7345):43\u201349. \nhttps:\/\/doi.org\/10.1038\/nature09906","journal-title":"Nature"},{"issue":"7261","key":"9792_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nature08451","volume":"461","author":"A Visel","year":"2009","unstructured":"Visel A, Rubin EM, Pennacchio LA (2009) Genomic views of distant-acting enhancers. Nature 461(7261):199\u2013205. \nhttps:\/\/doi.org\/10.1038\/nature08451","journal-title":"Nature"},{"issue":"1","key":"9792_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ng.1006","volume":"44","author":"D May","year":"2011","unstructured":"May D, Blow MJ, Kaplan T, McCulley DJ, Jensen BC, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Afzal V, Simpson PC, Rubin EM, Black BL, Bristow J, Pennacchio LA, Visel A (2011) Large-scale discovery of enhancers from human heart tissue. Nat Genet 44(1):89\u201393. \nhttps:\/\/doi.org\/10.1038\/ng.1006","journal-title":"Nat Genet"},{"issue":"9","key":"9792_CR36","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ng.650","volume":"42","author":"MJ Blow","year":"2010","unstructured":"Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, Afzal V, Bristow J, Ren B, Black BL, Rubin EM, Visel A, Pennacchio LA (2010) ChIP-Seq identification of weakly conserved heart enhancers. Nat Genet 42(9):806\u2013810. \nhttps:\/\/doi.org\/10.1038\/ng.650","journal-title":"Nat Genet"},{"issue":"3","key":"9792_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1101\/gr.098657.109","volume":"20","author":"L Narlikar","year":"2010","unstructured":"Narlikar L, Sakabe NJ, Blanski AA, Arimura FE, Westlund JM, Nobrega MA, Ovcharenko I (2010) Genome-wide discovery of human heart enhancers. Genome Res 20(3):381\u2013392. \nhttps:\/\/doi.org\/10.1101\/gr.098657.109","journal-title":"Genome Res"},{"issue":"4","key":"9792_CR38","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA (2013) Super-enhancers in the control of cell identity and disease. Cell 155(4):934\u2013947. \nhttps:\/\/doi.org\/10.1016\/j.cell.2013.09.053","journal-title":"Cell"},{"issue":"7414","key":"9792_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature11232","volume":"489","author":"RE Thurman","year":"2012","unstructured":"Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, Garg K, John S, Sandstrom R, Bates D, Boatman L, Canfield TK, Diegel M, Dunn D, Ebersol AK, Frum T, Giste E, Johnson AK, Johnson EM, Kutyavin T, Lajoie B, Lee BK, Lee K, London D, Lotakis D, Neph S, Neri F, Nguyen ED, Qu H, Reynolds AP, Roach V, Safi A, Sanchez ME, Sanyal A, Shafer A, Simon JM, Song L, Vong S, Weaver M, Yan Y, Zhang Z, Zhang Z, Lenhard B, Tewari M, Dorschner MO, Hansen RS, Navas PA, Stamatoyannopoulos G, Iyer VR, Lieb JD, Sunyaev SR, Akey JM, Sabo PJ, Kaul R, Furey TS, Dekker J, Crawford GE, Stamatoyannopoulos JA (2012) The accessible chromatin landscape of the human genome. Nature 489(7414):75\u201382. \nhttps:\/\/doi.org\/10.1038\/nature11232","journal-title":"Nature"},{"issue":"1","key":"9792_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ng.3167","volume":"47","author":"S Pott","year":"2015","unstructured":"Pott S, Lieb JD (2015) What are super-enhancers? Nat Genet 47(1):8\u201312. \nhttps:\/\/doi.org\/10.1038\/ng.3167","journal-title":"Nat Genet"},{"issue":"7552","key":"9792_CR41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature14289","volume":"521","author":"RC Adam","year":"2015","unstructured":"Adam RC, Yang H, Rockowitz S, Larsen SB, Nikolova M, Oristian DS, Polak L, Kadaja M, Asare A, Zheng D, Fuchs E (2015) Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 521(7552):366\u2013370. \nhttps:\/\/doi.org\/10.1038\/nature14289","journal-title":"Nature"},{"issue":"2","key":"9792_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molcel.2014.08.024","volume":"56","author":"JD Brown","year":"2014","unstructured":"Brown JD, Lin CY, Duan Q, Griffin G, Federation A, Paranal RM, Bair S, Newton G, Lichtman A, Kung A, Yang T, Wang H, Luscinskas FW, Croce K, Bradner JE, Plutzky J (2014) NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell 56(2):219\u2013231. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2014.08.024","journal-title":"Mol Cell"},{"issue":"7548","key":"9792_CR43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nature14154","volume":"520","author":"G Vahedi","year":"2015","unstructured":"Vahedi G, Kanno Y, Furumoto Y, Jiang K, Parker SC, Erdos MR, Davis SR, Roychoudhuri R, Restifo NP, Gadina M, Tang Z, Ruan Y, Collins FS, Sartorelli V, O\u2019Shea JJ (2015) Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 520(7548):558\u2013562. \nhttps:\/\/doi.org\/10.1038\/nature14154","journal-title":"Nature"},{"issue":"7572","key":"9792_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature14904","volume":"526","author":"HE Pelish","year":"2015","unstructured":"Pelish HE, Liau BB, Nitulescu II, Tangpeerachaikul A, Poss ZC, Da Silva DH, Caruso BT, Arefolov A, Fadeyi O, Christie AL, Du K, Banka D, Schneider EV, Jestel A, Zou G, Si C, Ebmeier CC, Bronson RT, Krivtsov AV, Myers AG, Kohl NE, Kung AL, Armstrong SA, Lemieux ME, Taatjes DJ, Shair MD (2015) Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature 526(7572):273\u2013276. \nhttps:\/\/doi.org\/10.1038\/nature14904","journal-title":"Nature"},{"issue":"8","key":"9792_CR45","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/leu.2014.70","volume":"28","author":"M Affer","year":"2014","unstructured":"Affer M, Chesi M, Chen WG, Keats JJ, Demchenko YN, Roschke AV, Van Wier S, Fonseca R, Bergsagel PL, Kuehl WM (2014) Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia 28(8):1725\u20131735. \nhttps:\/\/doi.org\/10.1038\/leu.2014.70","journal-title":"Leukemia"},{"key":"9792_CR46","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1038\/bcj.2014.13","volume":"4","author":"BA Walker","year":"2014","unstructured":"Walker BA, Wardell CP, Brioli A, Boyle E, Kaiser MF, Begum DB, Dahir NB, Johnson DC, Ross FM, Davies FE, Morgan GJ (2014) Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients. Blood Cancer J 4:e191. \nhttps:\/\/doi.org\/10.1038\/bcj.2014.13","journal-title":"Blood Cancer J"},{"issue":"1","key":"9792_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcdb.2006.11.012","volume":"18","author":"T Oka","year":"2007","unstructured":"Oka T, Xu J, Molkentin JD (2007) Re-employment of developmental transcription factors in adult heart disease. Semin Cell Dev Biol 18(1):117\u2013131. \nhttps:\/\/doi.org\/10.1016\/j.semcdb.2006.11.012","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"9792_CR48","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","volume":"92","author":"H Akazawa","year":"2003","unstructured":"Akazawa H, Komuro I (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92(10):1079\u20131088. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000072977.86706.23","journal-title":"Circ Res"},{"issue":"2","key":"9792_CR49","doi-asserted-by":"publisher","first-page":"e1001313","DOI":"10.1371\/journal.pgen.1001313","volume":"7","author":"J Schlesinger","year":"2011","unstructured":"Schlesinger J, Schueler M, Grunert M, Fischer JJ, Zhang Q, Krueger T, Lange M, Tonjes M, Dunkel I, Sperling SR (2011) The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet 7(2):e1001313. \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1001313","journal-title":"PLoS Genet"},{"key":"9792_CR50","doi-asserted-by":"publisher","first-page":"12923","DOI":"10.1038\/ncomms12923","volume":"7","author":"DE Dickel","year":"2016","unstructured":"Dickel DE, Barozzi I, Zhu Y, Fukuda-Yuzawa Y, Osterwalder M, Mannion BJ, May D, Spurrell CH, Plajzer-Frick I, Pickle CS, Lee E, Garvin TH, Kato M, Akiyama JA, Afzal V, Lee AY, Gorkin DU, Ren B, Rubin EM, Visel A, Pennacchio LA (2016) Genome-wide compendium and functional assessment of in vivo heart enhancers. Nat Commun 7:12923. \nhttps:\/\/doi.org\/10.1038\/ncomms12923","journal-title":"Nat Commun"},{"issue":"1","key":"9792_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cell.2012.07.035","volume":"151","author":"JA Wamstad","year":"2012","unstructured":"Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, Ding H, Wylie JN, Pico AR, Capra JA, Erwin G, Kattman SJ, Keller GM, Srivastava D, Levine SS, Pollard KS, Holloway AK, Boyer LA, Bruneau BG (2012) Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 151(1):206\u2013220. \nhttps:\/\/doi.org\/10.1016\/j.cell.2012.07.035","journal-title":"Cell"},{"issue":"4","key":"9792_CR52","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.cell.2013.07.020","volume":"154","author":"AB Stergachis","year":"2013","unstructured":"Stergachis AB, Neph S, Reynolds A, Humbert R, Miller B, Paige SL, Vernot B, Cheng JB, Thurman RE, Sandstrom R, Haugen E, Heimfeld S, Murry CE, Akey JM, Stamatoyannopoulos JA (2013) Developmental fate and cellular maturity encoded in human regulatory DNA landscapes. Cell 154(4):888\u2013903. \nhttps:\/\/doi.org\/10.1016\/j.cell.2013.07.020","journal-title":"Cell"},{"key":"9792_CR53","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1038\/ncomms5907","volume":"5","author":"A He","year":"2014","unstructured":"He A, Gu F, Hu Y, Ma Q, Ye LY, Akiyama JA, Visel A, Pennacchio LA, Pu WT (2014) Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease. Nat Commun 5:4907. \nhttps:\/\/doi.org\/10.1038\/ncomms5907","journal-title":"Nat Commun"},{"key":"9792_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.yjmcc.2014.08.009","volume":"76","author":"S Ounzain","year":"2014","unstructured":"Ounzain S, Pezzuto I, Micheletti R, Burdet F, Sheta R, Nemir M, Gonzales C, Sarre A, Alexanian M, Blow MJ, May D, Johnson R, Dauvillier J, Pennacchio LA, Pedrazzini T (2014) Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease. J Mol Cell Cardiol 76:55\u201370. \nhttps:\/\/doi.org\/10.1016\/j.yjmcc.2014.08.009","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"9792_CR55","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1242\/dev.138487","volume":"144","author":"CM Anderson","year":"2017","unstructured":"Anderson CM, Hu J, Thomas R, Gainous TB, Celona B, Sinha T, Dickel DE, Heidt AB, Xu SM, Bruneau BG, Pollard KS, Pennacchio LA, Black BL (2017) Cooperative activation of cardiac transcription through myocardin bridging of paired MEF2 sites. Development 144(7):1235\u20131241. \nhttps:\/\/doi.org\/10.1242\/dev.138487","journal-title":"Development"},{"issue":"3","key":"9792_CR56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cell.2012.01.030","volume":"148","author":"G Junion","year":"2012","unstructured":"Junion G, Spivakov M, Girardot C, Braun M, Gustafson EH, Birney E, Furlong EE (2012) A transcription factor collective defines cardiac cell fate and reflects lineage history. Cell 148(3):473\u2013486. \nhttps:\/\/doi.org\/10.1016\/j.cell.2012.01.030","journal-title":"Cell"},{"key":"9792_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-genet-110711-155437","volume":"46","author":"KM Lelli","year":"2012","unstructured":"Lelli KM, Slattery M, Mann RS (2012) Disentangling the many layers of eukaryotic transcriptional regulation. Annu Rev Genet 46:43\u201368. \nhttps:\/\/doi.org\/10.1146\/annurev-genet-110711-155437","journal-title":"Annu Rev Genet"},{"issue":"9","key":"9792_CR58","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrg3207","volume":"13","author":"F Spitz","year":"2012","unstructured":"Spitz F, Furlong EE (2012) Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 13(9):613\u2013626. \nhttps:\/\/doi.org\/10.1038\/nrg3207","journal-title":"Nat Rev Genet"},{"issue":"5","key":"9792_CR59","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.celrep.2014.04.042","volume":"7","author":"R Siersbaek","year":"2014","unstructured":"Siersbaek R, Rabiee A, Nielsen R, Sidoli S, Traynor S, Loft A, Poulsen LC, Rogowska-Wrzesinska A, Jensen ON, Mandrup S (2014) Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell Rep 7(5):1443\u20131455. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2014.04.042","journal-title":"Cell Rep"},{"issue":"2","key":"9792_CR60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1006\/dbio.2002.0603","volume":"244","author":"CL Lien","year":"2002","unstructured":"Lien CL, McAnally J, Richardson JA, Olson EN (2002) Cardiac-specific activity of an Nkx2-5 enhancer requires an evolutionarily conserved Smad binding site. Dev Biol 244(2):257\u2013266. \nhttps:\/\/doi.org\/10.1006\/dbio.2002.0603","journal-title":"Dev Biol"},{"issue":"7013","key":"9792_CR61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature03071","volume":"432","author":"H Lickert","year":"2004","unstructured":"Lickert H, Takeuchi JK, Von Both I, Walls JR, McAuliffe F, Adamson SL, Henkelman RM, Wrana JL, Rossant J, Bruneau BG (2004) Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 432(7013):107\u2013112. \nhttps:\/\/doi.org\/10.1038\/nature03071","journal-title":"Nature"},{"key":"9792_CR62","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","volume":"52","author":"TA McKinsey","year":"2012","unstructured":"McKinsey TA (2012) Therapeutic potential for HDAC inhibitors in the heart. Annu Rev Pharmacol Toxicol 52:303\u2013319. \nhttps:\/\/doi.org\/10.1146\/annurev-pharmtox-010611-134712","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"9792_CR63","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0968-0004(01)02031-X","volume":"27","author":"TA McKinsey","year":"2002","unstructured":"McKinsey TA, Zhang CL, Olson EN (2002) MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27(1):40\u201347","journal-title":"Trends Biochem Sci"},{"issue":"23","key":"9792_CR64","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1038\/onc.2013.32","volume":"32","author":"YJ Kim","year":"2013","unstructured":"Kim YJ, Greer CB, Cecchini KR, Harris LN, Tuck DP, Kim TH (2013) HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. Oncogene 32(23):2828\u20132835. \nhttps:\/\/doi.org\/10.1038\/onc.2013.32","journal-title":"Oncogene"},{"issue":"7","key":"9792_CR65","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.celrep.2015.10.013","volume":"13","author":"CB Greer","year":"2015","unstructured":"Greer CB, Tanaka Y, Kim YJ, Xie P, Zhang MQ, Park IH, Kim TH (2015) Histone deacetylases positively regulate transcription through the elongation machinery. Cell Rep 13(7):1444\u20131455. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2015.10.013","journal-title":"Cell Rep"},{"issue":"1","key":"9792_CR66","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc1779","volume":"6","author":"S Minucci","year":"2006","unstructured":"Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6(1):38\u201351. \nhttps:\/\/doi.org\/10.1038\/nrc1779","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"9792_CR67","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0092-8674(00)80054-9","volume":"98","author":"H Chen","year":"1999","unstructured":"Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98(5):675\u2013686","journal-title":"Cell"},{"issue":"28","key":"9792_CR68","doi-asserted-by":"publisher","first-page":"25562","DOI":"10.1074\/jbc.M201196200","volume":"277","author":"D Wolf","year":"2002","unstructured":"Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T (2002) Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem 277(28):25562\u201325567. \nhttps:\/\/doi.org\/10.1074\/jbc.M201196200","journal-title":"J Biol Chem"},{"issue":"11","key":"9792_CR69","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1096\/fj.09-132415","volume":"23","author":"S Chandrasekaran","year":"2009","unstructured":"Chandrasekaran S, Peterson RE, Mani SK, Addy B, Buchholz AL, Xu L, Thiyagarajan T, Kasiganesan H, Kern CB, Menick DR (2009) Histone deacetylases facilitate sodium\/calcium exchanger up-regulation in adult cardiomyocytes. FASEB J 23(11):3851\u20133864. \nhttps:\/\/doi.org\/10.1096\/fj.09-132415","journal-title":"FASEB J"},{"key":"9792_CR70","doi-asserted-by":"publisher","unstructured":"Jeong MY, Lin YH, Wennersten SA, Demos-Davies KM, Cavasin MA, Mahaffey JH, Monzani V, Saripalli C, Mascagni P, Reece TB, Ambardekar AV, Granzier HL, Dinarello CA, McKinsey TA (2018) Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism. Sci Transl Med 10(427). \nhttps:\/\/doi.org\/10.1126\/scitranslmed.aao0144","DOI":"10.1126\/scitranslmed.aao0144"},{"issue":"3","key":"9792_CR71","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1172\/JCI24144","volume":"115","author":"TA McKinsey","year":"2005","unstructured":"McKinsey TA, Olson EN (2005) Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 115(3):538\u2013546. \nhttps:\/\/doi.org\/10.1172\/JCI24144","journal-title":"J Clin Invest"},{"issue":"4","key":"9792_CR72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","volume":"19","author":"Z Yang","year":"2005","unstructured":"Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K, Zhou Q (2005) Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 19(4):535\u2013545. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2005.06.029","journal-title":"Mol Cell"},{"issue":"7327","key":"9792_CR73","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE (2010) Selective inhibition of BET bromodomains. Nature 468(7327):1067\u20131073. \nhttps:\/\/doi.org\/10.1038\/nature09504","journal-title":"Nature"},{"issue":"2","key":"9792_CR74","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153(2):320\u2013334. \nhttps:\/\/doi.org\/10.1016\/j.cell.2013.03.036","journal-title":"Cell"},{"issue":"6","key":"9792_CR75","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","volume":"24","author":"B Chapuy","year":"2013","unstructured":"Chapuy B, McKeown MR, Lin CY, Monti S, Roemer MG, Qi J, Rahl PB, Sun HH, Yeda KT, Doench JG, Reichert E, Kung AL, Rodig SJ, Young RA, Shipp MA, Bradner JE (2013) Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 24(6):777\u2013790. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2013.11.003","journal-title":"Cancer Cell"},{"issue":"2","key":"9792_CR76","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","volume":"157","author":"S Groschel","year":"2014","unstructured":"Groschel S, Sanders MA, Hoogenboezem R, de Wit E, Bouwman BAM, Erpelinck C, van der Velden VHJ, Havermans M, Avellino R, van Lom K, Rombouts EJ, van Duin M, Dohner K, Beverloo HB, Bradner JE, Dohner H, Lowenberg B, Valk PJM, Bindels EMJ, de Laat W, Delwel R (2014) A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 157(2):369\u2013381. \nhttps:\/\/doi.org\/10.1016\/j.cell.2014.02.019","journal-title":"Cell"},{"issue":"6","key":"9792_CR77","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146(6):904\u2013917. \nhttps:\/\/doi.org\/10.1016\/j.cell.2011.08.017","journal-title":"Cell"},{"issue":"7370","key":"9792_CR78","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10334","volume":"478","author":"J Zuber","year":"2011","unstructured":"Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, Taylor MJ, Johns C, Chicas A, Mulloy JC, Kogan SC, Brown P, Valent P, Bradner JE, Lowe SW, Vakoc CR (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478(7370):524\u2013528. \nhttps:\/\/doi.org\/10.1038\/nature10334","journal-title":"Nature"},{"issue":"5","key":"9792_CR79","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.celrep.2016.06.074","volume":"16","author":"MS Stratton","year":"2016","unstructured":"Stratton MS, Lin CY, Anand P, Tatman PD, Ferguson BS, Wickers ST, Ambardekar AV, Sucharov CC, Bradner JE, Haldar SM, McKinsey TA (2016) Signal-dependent recruitment of BRD4 to cardiomyocyte super-enhancers is suppressed by a microRNA. Cell Rep 16(5):1366\u20131378. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2016.06.074","journal-title":"Cell Rep"},{"issue":"11","key":"9792_CR80","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrg2901","volume":"11","author":"S Malik","year":"2010","unstructured":"Malik S, Roeder RG (2010) The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 11(11):761\u2013772. \nhttps:\/\/doi.org\/10.1038\/nrg2901","journal-title":"Nat Rev Genet"},{"issue":"6","key":"9792_CR81","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.molcel.2009.12.011","volume":"36","author":"JA D\u2019Alessio","year":"2009","unstructured":"D\u2019Alessio JA, Wright KJ, Tjian R (2009) Shifting players and paradigms in cell-specific transcription. Mol Cell 36(6):924\u2013931. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2009.12.011","journal-title":"Mol Cell"},{"issue":"1","key":"9792_CR82","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molcel.2008.09.009","volume":"32","author":"MD Deato","year":"2008","unstructured":"Deato MD, Marr MT, Sottero T, Inouye C, Hu P, Tjian R (2008) MyoD targets TAF3\/TRF3 to activate myogenin transcription. Mol Cell 32(1):96\u2013105. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2008.09.009","journal-title":"Mol Cell"},{"issue":"15","key":"9792_CR83","doi-asserted-by":"publisher","first-page":"92476","DOI":"10.1172\/jci.insight.92476","volume":"2","author":"DD Hall","year":"2017","unstructured":"Hall DD, Ponce JM, Chen B, Spitler KM, Alexia A, Oudit GY, Song LS, Grueter CE (2017) Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure. JCI Insight 2(15):92476. \nhttps:\/\/doi.org\/10.1172\/jci.insight.92476","journal-title":"JCI Insight"},{"issue":"7314","key":"9792_CR84","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nature09380","volume":"467","author":"MH Kagey","year":"2010","unstructured":"Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS, Taatjes DJ, Dekker J, Young RA (2010) Mediator and cohesin connect gene expression and chromatin architecture. Nature 467(7314):430\u2013435. \nhttps:\/\/doi.org\/10.1038\/nature09380","journal-title":"Nature"},{"issue":"10","key":"9792_CR85","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s00134-011-2296-z","volume":"37","author":"S Borik","year":"2011","unstructured":"Borik S, Simon AJ, Nevo-Caspi Y, Mishali D, Amariglio N, Rechavi G, Paret G (2011) Increased RNA editing in children with cyanotic congenital heart disease. Intensive Care Med 37(10):1664\u20131671. \nhttps:\/\/doi.org\/10.1007\/s00134-011-2296-z","journal-title":"Intensive Care Med"},{"issue":"23","key":"9792_CR86","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1161\/01.CIR.0000103684.77636.CD","volume":"108","author":"N Muncke","year":"2003","unstructured":"Muncke N, Jung C, Rudiger H, Ulmer H, Roeth R, Hubert A, Goldmuntz E, Driscoll D, Goodship J, Schon K, Rappold G (2003) Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation 108(23):2843\u20132850. \nhttps:\/\/doi.org\/10.1161\/01.CIR.0000103684.77636.CD","journal-title":"Circulation"},{"issue":"10","key":"9792_CR87","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ejhg.2013.17","volume":"21","author":"R Asadollahi","year":"2013","unstructured":"Asadollahi R, Oneda B, Sheth F, Azzarello-Burri S, Baldinger R, Joset P, Latal B, Knirsch W, Desai S, Baumer A, Houge G, Andrieux J, Rauch A (2013) Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. Eur J Hum Genet 21(10):1100\u20131104. \nhttps:\/\/doi.org\/10.1038\/ejhg.2013.17","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"9792_CR88","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.gene.2012.12.051","volume":"516","author":"CP Chen","year":"2013","unstructured":"Chen CP, Chen YY, Chern SR, Wu PS, Su JW, Chen YT, Chen LF, Wang W (2013) Prenatal diagnosis and molecular cytogenetic characterization of de novo partial trisomy 12q (12q24.21-->qter) and partial monosomy 6q (6q27-->qter) associated with coarctation of the aorta, ventriculomegaly and thickened nuchal fold. Gene 516(1):138\u2013142. \nhttps:\/\/doi.org\/10.1016\/j.gene.2012.12.051","journal-title":"Gene"},{"issue":"9596","key":"9792_CR89","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0140-6736(07)61601-8","volume":"370","author":"LJ Kobrynski","year":"2007","unstructured":"Kobrynski LJ, Sullivan KE (2007) Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370(9596):1443\u20131452. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(07)61601-8","journal-title":"Lancet"},{"issue":"8","key":"9792_CR90","doi-asserted-by":"publisher","first-page":"e0160755","DOI":"10.1371\/journal.pone.0160755","volume":"11","author":"Y Jia","year":"2016","unstructured":"Jia Y, Chang HC, Schipma MJ, Liu J, Shete V, Liu N, Sato T, Thorp EB, Barger PM, Zhu YJ, Viswakarma N, Kanwar YS, Ardehali H, Thimmapaya B, Reddy JK (2016) Cardiomyocyte-specific ablation of Med1 subunit of the Mediator complex causes lethal dilated cardiomyopathy in mice. PLoS One 11(8):e0160755. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0160755","journal-title":"PLoS One"},{"issue":"4","key":"9792_CR91","doi-asserted-by":"publisher","first-page":"H768","DOI":"10.1152\/ajpheart.00728.2016","volume":"312","author":"KM Spitler","year":"2017","unstructured":"Spitler KM, Ponce JM, Oudit GY, Hall DD, Grueter CE (2017) Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming. Am J Physiol Heart Circ Physiol 312(4):H768\u2013H780. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00728.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9792_CR92","doi-asserted-by":"publisher","unstructured":"Hall DD, Spitler KM, Grueter CE (2018) Disruption of cardiac Med1 inhibits RNA polymerase-II promoter occupancy and promotes chromatin remodeling. Am J Physiol Heart Circ Physiol. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00580.2018","DOI":"10.1152\/ajpheart.00580.2018"},{"issue":"14","key":"9792_CR93","doi-asserted-by":"publisher","first-page":"91920","DOI":"10.1172\/jci.insight.91920","volume":"2","author":"KK Baskin","year":"2017","unstructured":"Baskin KK, Makarewich CA, DeLeon SM, Ye W, Chen B, Beetz N, Schrewe H, Bassel-Duby R, Olson EN (2017) MED12 regulates a transcriptional network of calcium-handling genes in the heart. JCI Insight 2(14):91920. \nhttps:\/\/doi.org\/10.1172\/jci.insight.91920","journal-title":"JCI Insight"},{"issue":"12","key":"9792_CR94","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.15252\/emmm.201404218","volume":"6","author":"KK Baskin","year":"2014","unstructured":"Baskin KK, Grueter CE, Kusminski CM, Holland WL, Bookout AL, Satapati S, Kong YM, Burgess SC, Malloy CR, Scherer PE, Newgard CB, Bassel-Duby R, Olson EN (2014) MED13-dependent signaling from the heart confers leanness by enhancing metabolism in adipose tissue and liver. EMBO Mol Med 6(12):1610\u20131621. \nhttps:\/\/doi.org\/10.15252\/emmm.201404218","journal-title":"EMBO Mol Med"},{"issue":"3","key":"9792_CR95","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cell.2012.03.029","volume":"149","author":"CE Grueter","year":"2012","unstructured":"Grueter CE, van Rooij E, Johnson BA, DeLeon SM, Sutherland LB, Qi X, Gautron L, Elmquist JK, Bassel-Duby R, Olson EN (2012) A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149(3):671\u2013683. \nhttps:\/\/doi.org\/10.1016\/j.cell.2012.03.029","journal-title":"Cell"},{"key":"9792_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yjmcc.2019.01.007","volume":"129","author":"RA Minerath","year":"2019","unstructured":"Minerath RA, Dewey CM, Hall DD, Grueter CE (2019) Regulation of cardiac transcription by thyroid hormone and Med13. J Mol Cell Cardiol 129:27\u201338. \nhttps:\/\/doi.org\/10.1016\/j.yjmcc.2019.01.007","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"9792_CR97","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.stem.2016.08.004","volume":"19","author":"B Aranda-Orgilles","year":"2016","unstructured":"Aranda-Orgilles B, Saldana-Meyer R, Wang E, Trompouki E, Fassl A, Lau S, Mullenders J, Rocha PP, Raviram R, Guillamot M, Sanchez-Diaz M, Wang K, Kayembe C, Zhang N, Amoasii L, Choudhuri A, Skok JA, Schober M, Reinberg D, Sicinski P, Schrewe H, Tsirigos A, Zon LI, Aifantis I (2016) MED12 regulates HSC-specific enhancers independently of Mediator kinase activity to control hematopoiesis. Cell Stem Cell 19(6):784\u2013799. \nhttps:\/\/doi.org\/10.1016\/j.stem.2016.08.004","journal-title":"Cell Stem Cell"},{"issue":"11","key":"9792_CR98","doi-asserted-by":"publisher","first-page":"e00573","DOI":"10.1128\/MCB.00573-17","volume":"38","author":"E Kuuluvainen","year":"2018","unstructured":"Kuuluvainen E, Domenech-Moreno E, Niemela EH, Makela TP (2018) Depletion of Mediator kinase module subunits represses superenhancer-associated genes in colon cancer cells. Mol Cell Biol 38(11):e00573\u2013e00517. \nhttps:\/\/doi.org\/10.1128\/MCB.00573-17","journal-title":"Mol Cell Biol"},{"issue":"3","key":"9792_CR99","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.celrep.2016.03.054","volume":"15","author":"AS Bhagwat","year":"2016","unstructured":"Bhagwat AS, Roe JS, Mok BYL, Hohmann AF, Shi J, Vakoc CR (2016) BET Bromodomain inhibition releases the Mediator complex from select cis-regulatory elements. Cell Rep 15(3):519\u2013530. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2016.03.054","journal-title":"Cell Rep"},{"issue":"1","key":"9792_CR100","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/trns.1.1.12373","volume":"1","author":"MD Galbraith","year":"2010","unstructured":"Galbraith MD, Donner AJ, Espinosa JM (2010) CDK8: a positive regulator of transcription. Transcription 1(1):4\u201312. \nhttps:\/\/doi.org\/10.4161\/trns.1.1.12373","journal-title":"Transcription"},{"issue":"43","key":"9792_CR101","doi-asserted-by":"publisher","first-page":"15788","DOI":"10.1073\/pnas.0607483103","volume":"103","author":"H Elmlund","year":"2006","unstructured":"Elmlund H, Baraznenok V, Lindahl M, Samuelsen CO, Koeck PJ, Holmberg S, Hebert H, Gustafsson CM (2006) The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II. Proc Natl Acad Sci U S A 103(43):15788\u201315793. \nhttps:\/\/doi.org\/10.1073\/pnas.0607483103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9792_CR102","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nsmb.1752","volume":"17","author":"AJ Donner","year":"2010","unstructured":"Donner AJ, Ebmeier CC, Taatjes DJ, Espinosa JM (2010) CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat Struct Mol Biol 17(2):194\u2013201. \nhttps:\/\/doi.org\/10.1038\/nsmb.1752","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"9792_CR103","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2013.04.048","volume":"153","author":"MD Galbraith","year":"2013","unstructured":"Galbraith MD, Allen MA, Bensard CL, Wang X, Schwinn MK, Qin B, Long HW, Daniels DL, Hahn WC, Dowell RD, Espinosa JM (2013) HIF1A employs CDK8-Mediator to stimulate RNAPII elongation in response to hypoxia. Cell 153(6):1327\u20131339. \nhttps:\/\/doi.org\/10.1016\/j.cell.2013.04.048","journal-title":"Cell"},{"issue":"38","key":"9792_CR104","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1073\/pnas.1710467114","volume":"114","author":"M Chen","year":"2017","unstructured":"Chen M, Liang J, Ji H, Yang Z, Altilia S, Hu B, Schronce A, McDermott MSJ, Schools GP, Lim CU, Oliver D, Shtutman MS, Lu T, Stark GR, Porter DC, Broude EV, Roninson IB (2017) CDK8\/19 Mediator kinases potentiate induction of transcription by NFkappaB. Proc Natl Acad Sci U S A 114(38):10208\u201310213. \nhttps:\/\/doi.org\/10.1073\/pnas.1710467114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9792_CR105","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.celrep.2017.10.058","volume":"21","author":"MD Galbraith","year":"2017","unstructured":"Galbraith MD, Andrysik Z, Pandey A, Hoh M, Bonner EA, Hill AA, Sullivan KD, Espinosa JM (2017) CDK8 kinase activity promotes glycolysis. Cell Rep 21(6):1495\u20131506. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2017.10.058","journal-title":"Cell Rep"},{"issue":"10","key":"9792_CR106","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1128\/MCB.01541-09","volume":"30","author":"M Belakavadi","year":"2010","unstructured":"Belakavadi M, Fondell JD (2010) Cyclin-dependent kinase 8 positively cooperates with Mediator to promote thyroid hormone receptor-dependent transcriptional activation. Mol Cell Biol 30(10):2437\u20132448. \nhttps:\/\/doi.org\/10.1128\/MCB.01541-09","journal-title":"Mol Cell Biol"},{"issue":"7212","key":"9792_CR107","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature07179","volume":"455","author":"R Firestein","year":"2008","unstructured":"Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M, Hahn WC (2008) CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455(7212):547\u2013551. \nhttps:\/\/doi.org\/10.1038\/nature07179","journal-title":"Nature"},{"issue":"7212","key":"9792_CR108","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature07310","volume":"455","author":"EJ Morris","year":"2008","unstructured":"Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, Kwon EJ, Haigis KM, Naar AM, Dyson NJ (2008) E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 455(7212):552\u2013556. \nhttps:\/\/doi.org\/10.1038\/nature07310","journal-title":"Nature"},{"issue":"4","key":"9792_CR109","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","volume":"139","author":"C Alarcon","year":"2009","unstructured":"Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, Sapkota G, Pan D, Massague J (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139(4):757\u2013769. \nhttps:\/\/doi.org\/10.1016\/j.cell.2009.09.035","journal-title":"Cell"},{"issue":"2","key":"9792_CR110","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","volume":"38","author":"J Bancerek","year":"2013","unstructured":"Bancerek J, Poss ZC, Steinparzer I, Sedlyarov V, Pfaffenwimmer T, Mikulic I, Dolken L, Strobl B, Muller M, Taatjes DJ, Kovarik P (2013) CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response. Immunity 38(2):250\u2013262. \nhttps:\/\/doi.org\/10.1016\/j.immuni.2012.10.017","journal-title":"Immunity"},{"issue":"12","key":"9792_CR111","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1101\/gad.2060811","volume":"25","author":"E Aragon","year":"2011","unstructured":"Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massague J, Macias MJ (2011) A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev 25(12):1275\u20131288. \nhttps:\/\/doi.org\/10.1101\/gad.2060811","journal-title":"Genes Dev"},{"issue":"7","key":"9792_CR112","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1172\/JCI61462","volume":"122","author":"X Zhao","year":"2012","unstructured":"Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J, Sun Y, Yang ES, Liu LP, Vaitheesvaran B, Bridges L, Kurland IJ, Strich R, Ni JQ, Wang C, Ericsson J, Pessin JE, Ji JY, Yang F (2012) Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 122(7):2417\u20132427. \nhttps:\/\/doi.org\/10.1172\/JCI61462","journal-title":"J Clin Invest"},{"issue":"2","key":"9792_CR113","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.celrep.2016.03.030","volume":"15","author":"ZC Poss","year":"2016","unstructured":"Poss ZC, Ebmeier CC, Odell AT, Tangpeerachaikul A, Lee T, Pelish HE, Shair MD, Dowell RD, Old WM, Taatjes DJ (2016) Identification of Mediator kinase substrates in human cells using cortistatin A and quantitative phosphoproteomics. Cell Rep 15(2):436\u2013450. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2016.03.030","journal-title":"Cell Rep"},{"issue":"3","key":"9792_CR114","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1128\/MCB.00993-08","volume":"29","author":"MT Knuesel","year":"2009","unstructured":"Knuesel MT, Meyer KD, Donner AJ, Espinosa JM, Taatjes DJ (2009) The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of Mediator. Mol Cell Biol 29(3):650\u2013661. \nhttps:\/\/doi.org\/10.1128\/MCB.00993-08","journal-title":"Mol Cell Biol"},{"issue":"10","key":"9792_CR115","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/emboj.2008.78","volume":"27","author":"KD Meyer","year":"2008","unstructured":"Meyer KD, Donner AJ, Knuesel MT, York AG, Espinosa JM, Taatjes DJ (2008) Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3. EMBO J 27(10):1447\u20131457. \nhttps:\/\/doi.org\/10.1038\/emboj.2008.78","journal-title":"EMBO J"},{"issue":"6800","key":"9792_CR116","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/35024111","volume":"407","author":"S Akoulitchev","year":"2000","unstructured":"Akoulitchev S, Chuikov S, Reinberg D (2000) TFIIH is negatively regulated by cdk8-containing Mediator complexes. Nature 407(6800):102\u2013106. \nhttps:\/\/doi.org\/10.1038\/35024111","journal-title":"Nature"},{"issue":"7327","key":"9792_CR117","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/nature09590","volume":"468","author":"A Kapoor","year":"2010","unstructured":"Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, Menendez S, Vardabasso C, Leroy G, Vidal CI, Polsky D, Osman I, Garcia BA, Hernando E, Bernstein E (2010) The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 468(7327):1105\u20131109. \nhttps:\/\/doi.org\/10.1038\/nature09590","journal-title":"Nature"},{"issue":"1","key":"9792_CR118","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molcel.2007.05.026","volume":"27","author":"AJ Donner","year":"2007","unstructured":"Donner AJ, Szostek S, Hoover JM, Espinosa JM (2007) CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell 27(1):121\u2013133. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2007.05.026","journal-title":"Mol Cell"},{"key":"9792_CR119","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.biochi.2013.10.004","volume":"97","author":"J Nemet","year":"2014","unstructured":"Nemet J, Jelicic B, Rubelj I, Sopta M (2014) The two faces of Cdk8, a positive\/negative regulator of transcription. Biochimie 97:22\u201327. \nhttps:\/\/doi.org\/10.1016\/j.biochi.2013.10.004","journal-title":"Biochimie"},{"issue":"12","key":"9792_CR120","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nchembio.1952","volume":"11","author":"T Dale","year":"2015","unstructured":"Dale T, Clarke PA, Esdar C, Waalboer D, Adeniji-Popoola O, Ortiz-Ruiz MJ, Mallinger A, Samant RS, Czodrowski P, Musil D, Schwarz D, Schneider K, Stubbs M, Ewan K, Fraser E, TePoele R, Court W, Box G, Valenti M, de Haven Brandon A, Gowan S, Rohdich F, Raynaud F, Schneider R, Poeschke O, Blaukat A, Workman P, Schiemann K, Eccles SA, Wienke D, Blagg J (2015) A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease. Nat Chem Biol 11(12):973\u2013980. \nhttps:\/\/doi.org\/10.1038\/nchembio.1952","journal-title":"Nat Chem Biol"},{"issue":"20","key":"9792_CR121","doi-asserted-by":"publisher","first-page":"33779","DOI":"10.18632\/oncotarget.16810","volume":"8","author":"T Rzymski","year":"2017","unstructured":"Rzymski T, Mikula M, Zylkiewicz E, Dreas A, Wiklik K, Golas A, Wojcik K, Masiejczyk M, Wrobel A, Dolata I, Kitlinska A, Statkiewicz M, Kuklinska U, Goryca K, Sapala L, Grochowska A, Cabaj A, Szajewska-Skuta M, Gabor-Worwa E, Kucwaj K, Bialas A, Radzimierski A, Combik M, Woyciechowski J, Mikulski M, Windak R, Ostrowski J, Brzozka K (2017) SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains. Oncotarget 8(20):33779\u201333795. \nhttps:\/\/doi.org\/10.18632\/oncotarget.16810","journal-title":"Oncotarget"},{"issue":"34","key":"9792_CR122","doi-asserted-by":"publisher","first-page":"13799","DOI":"10.1073\/pnas.1206906109","volume":"109","author":"DC Porter","year":"2012","unstructured":"Porter DC, Farmaki E, Altilia S, Schools GP, West DK, Chen M, Chang BD, Puzyrev AT, Lim CU, Rokow-Kittell R, Friedhoff LT, Papavassiliou AG, Kalurupalle S, Hurteau G, Shi J, Baran PS, Gyorffy B, Wentland MP, Broude EV, Kiaris H, Roninson IB (2012) Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A 109(34):13799\u201313804. \nhttps:\/\/doi.org\/10.1073\/pnas.1206906109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9792_CR123","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.molcel.2015.12.003","volume":"61","author":"R Schuller","year":"2016","unstructured":"Schuller R, Forne I, Straub T, Schreieck A, Texier Y, Shah N, Decker TM, Cramer P, Imhof A, Eick D (2016) Heptad-specific phosphorylation of RNA polymerase II CTD. Mol Cell 61(2):305\u2013314. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2015.12.003","journal-title":"Mol Cell"},{"issue":"24","key":"9792_CR124","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1093\/emboj\/17.24.7395","volume":"17","author":"T Wada","year":"1998","unstructured":"Wada T, Takagi T, Yamaguchi Y, Watanabe D, Handa H (1998) Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J 17(24):7395\u20137403. \nhttps:\/\/doi.org\/10.1093\/emboj\/17.24.7395","journal-title":"EMBO J"},{"issue":"8","key":"9792_CR125","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1128\/MCB.20.8.2629-2634.2000","volume":"20","author":"DH Price","year":"2000","unstructured":"Price DH (2000) P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 20(8):2629\u20132634","journal-title":"Mol Cell Biol"},{"issue":"1","key":"9792_CR126","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/MCB.22.1.321-331.2002","volume":"22","author":"R Taube","year":"2002","unstructured":"Taube R, Lin X, Irwin D, Fujinaga K, Peterlin BM (2002) Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol Cell Biol 22(1):321\u2013331","journal-title":"Mol Cell Biol"},{"issue":"11","key":"9792_CR127","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1128\/MCB.18.11.6729","volume":"18","author":"M Abdellatif","year":"1998","unstructured":"Abdellatif M, Packer SE, Michael LH, Zhang D, Charng MJ, Schneider MD (1998) A Ras-dependent pathway regulates RNA polymerase II phosphorylation in cardiac myocytes: implications for cardiac hypertrophy. Mol Cell Biol 18(11):6729\u20136736","journal-title":"Mol Cell Biol"},{"issue":"17","key":"9792_CR128","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1038\/sj.emboj.7600351","volume":"23","author":"M Sano","year":"2004","unstructured":"Sano M, Wang SC, Shirai M, Scaglia F, Xie M, Sakai S, Tanaka T, Kulkarni PA, Barger PM, Youker KA, Taffet GE, Hamamori Y, Michael LH, Craigen WJ, Schneider MD (2004) Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure. EMBO J 23(17):3559\u20133569. \nhttps:\/\/doi.org\/10.1038\/sj.emboj.7600351","journal-title":"EMBO J"},{"issue":"1","key":"9792_CR129","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.celrep.2014.08.055","volume":"9","author":"R Di Micco","year":"2014","unstructured":"Di Micco R, Fontanals-Cirera B, Low V, Ntziachristos P, Yuen SK, Lovell CD, Dolgalev I, Yonekubo Y, Zhang G, Rusinova E, Gerona-Navarro G, Canamero M, Ohlmeyer M, Aifantis I, Zhou MM, Tsirigos A, Hernando E (2014) Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes. Cell Rep 9(1):234\u2013247. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2014.08.055","journal-title":"Cell Rep"},{"issue":"1","key":"9792_CR130","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","volume":"67","author":"GE Winter","year":"2017","unstructured":"Winter GE, Mayer A, Buckley DL, Erb MA, Roderick JE, Vittori S, Reyes JM, di Iulio J, Souza A, Ott CJ, Roberts JM, Zeid R, Scott TG, Paulk J, Lachance K, Olson CM, Dastjerdi S, Bauer S, Lin CY, Gray NS, Kelliher MA, Churchman LS, Bradner JE (2017) BET Bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment. Mol Cell 67(1):5\u201318 e19. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2017.06.004","journal-title":"Mol Cell"},{"issue":"3","key":"9792_CR131","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molcel.2013.07.010","volume":"51","author":"MU Kaikkonen","year":"2013","unstructured":"Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, Chun HB, Tough DF, Prinjha RK, Benner C, Glass CK (2013) Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell 51(3):310\u2013325. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2013.07.010","journal-title":"Mol Cell"},{"issue":"7414","key":"9792_CR132","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C, Marinov GK, Khatun J, Williams BA, Zaleski C, Rozowsky J, Roder M, Kokocinski F, Abdelhamid RF, Alioto T, Antoshechkin I, Baer MT, Bar NS, Batut P, Bell K, Bell I, Chakrabortty S, Chen X, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Falconnet E, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood MJ, Gao H, Gonzalez D, Gordon A, Gunawardena H, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Luo OJ, Park E, Persaud K, Preall JB, Ribeca P, Risk B, Robyr D, Sammeth M, Schaffer L, See LH, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang H, Wrobel J, Yu Y, Ruan X, Hayashizaki Y, Harrow J, Gerstein M, Hubbard T, Reymond A, Antonarakis SE, Hannon G, Giddings MC, Ruan Y, Wold B, Carninci P, Guigo R, Gingeras TR (2012) Landscape of transcription in human cells. Nature 489(7414):101\u2013108. \nhttps:\/\/doi.org\/10.1038\/nature11233","journal-title":"Nature"},{"issue":"6","key":"9792_CR133","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tig.2012.02.008","volume":"28","author":"C Buecker","year":"2012","unstructured":"Buecker C, Wysocka J (2012) Enhancers as information integration hubs in development: lessons from genomics. Trends Genet 28(6):276\u2013284. \nhttps:\/\/doi.org\/10.1016\/j.tig.2012.02.008","journal-title":"Trends Genet"},{"key":"9792_CR134","doi-asserted-by":"publisher","unstructured":"Azofeifa JG, Allen MA, Hendrix JR, Read T, Rubin JD, Dowell RD (2018) Enhancer RNA profiling predicts transcription factor activity. Genome Res doi:\nhttps:\/\/doi.org\/10.1101\/gr.225755.117","DOI":"10.1101\/gr.225755.117"},{"issue":"20","key":"9792_CR135","doi-asserted-by":"publisher","first-page":"12537","DOI":"10.1093\/nar\/gku1018","volume":"42","author":"AR Banerjee","year":"2014","unstructured":"Banerjee AR, Kim YJ, Kim TH (2014) A novel virus-inducible enhancer of the interferon-beta gene with tightly linked promoter and enhancer activities. Nucleic Acids Res 42(20):12537\u201312554. \nhttps:\/\/doi.org\/10.1093\/nar\/gku1018","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"9792_CR136","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1073\/pnas.1324151111","volume":"111","author":"CL Hsieh","year":"2014","unstructured":"Hsieh CL, Fei T, Chen Y, Li T, Gao Y, Wang X, Sun T, Sweeney CJ, Lee GS, Chen S, Balk SP, Liu XS, Brown M, Kantoff PW (2014) Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc Natl Acad Sci U S A 111(20):7319\u20137324. \nhttps:\/\/doi.org\/10.1073\/pnas.1324151111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9792_CR137","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.molcel.2012.11.021","volume":"49","author":"CA Melo","year":"2013","unstructured":"Melo CA, Drost J, Wijchers PJ, van de Werken H, de Wit E, Oude Vrielink JA, Elkon R, Melo SA, Leveille N, Kalluri R, de Laat W, Agami R (2013) eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell 49(3):524\u2013535. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2012.11.021","journal-title":"Mol Cell"},{"issue":"7455","key":"9792_CR138","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature12210","volume":"498","author":"W Li","year":"2013","unstructured":"Li W, Notani D, Ma Q, Tanasa B, Nunez E, Chen AY, Merkurjev D, Zhang J, Ohgi K, Song X, Oh S, Kim HS, Glass CK, Rosenfeld MG (2013) Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498(7455):516\u2013520. \nhttps:\/\/doi.org\/10.1038\/nature12210","journal-title":"Nature"},{"issue":"7438","key":"9792_CR139","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature11884","volume":"494","author":"F Lai","year":"2013","unstructured":"Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA, Shiekhattar R (2013) Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 494(7438):497\u2013501. \nhttps:\/\/doi.org\/10.1038\/nature11884","journal-title":"Nature"},{"issue":"1","key":"9792_CR140","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molcel.2014.08.023","volume":"56","author":"K Schaukowitch","year":"2014","unstructured":"Schaukowitch K, Joo JY, Liu X, Watts JK, Martinez C, Kim TK (2014) Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell 56(1):29\u201342. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2014.08.023","journal-title":"Mol Cell"},{"issue":"1","key":"9792_CR141","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(00)80713-8","volume":"97","author":"Y Yamaguchi","year":"1999","unstructured":"Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A, Sugimoto S, Hasegawa J, Handa H (1999) NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97(1):41\u201351","journal-title":"Cell"},{"issue":"9","key":"9792_CR142","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1128\/MCB.22.9.2918-2927.2002","volume":"22","author":"Y Yamaguchi","year":"2002","unstructured":"Yamaguchi Y, Inukai N, Narita T, Wada T, Handa H (2002) Evidence that negative elongation factor represses transcription elongation through binding to a -inducing factor\/RNA polymerase II complex and RNA. Mol Cell Biol 22(9):2918\u20132927","journal-title":"Mol Cell Biol"},{"issue":"12","key":"9792_CR143","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nsmb.2912","volume":"21","author":"T Kanno","year":"2014","unstructured":"Kanno T, Kanno Y, LeRoy G, Campos E, Sun HW, Brooks SR, Vahedi G, Heightman TD, Garcia BA, Reinberg D, Siebenlist U, O\u2019Shea JJ, Ozato K (2014) BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat Struct Mol Biol 21(12):1047\u20131057. \nhttps:\/\/doi.org\/10.1038\/nsmb.2912","journal-title":"Nat Struct Mol Biol"},{"issue":"7398","key":"9792_CR144","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11082","volume":"485","author":"JR Dixon","year":"2012","unstructured":"Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, Ren B (2012) Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485(7398):376\u2013380. \nhttps:\/\/doi.org\/10.1038\/nature11082","journal-title":"Nature"},{"issue":"4","key":"9792_CR145","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrg3663","volume":"15","author":"CT Ong","year":"2014","unstructured":"Ong CT, Corces VG (2014) CTCF: an architectural protein bridging genome topology and function. Nat Rev Genet 15(4):234\u2013246. \nhttps:\/\/doi.org\/10.1038\/nrg3663","journal-title":"Nat Rev Genet"},{"issue":"7","key":"9792_CR146","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SS Rao","year":"2014","unstructured":"Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, Sanborn AL, Machol I, Omer AD, Lander ES, Aiden EL (2014) A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159(7):1665\u20131680. \nhttps:\/\/doi.org\/10.1016\/j.cell.2014.11.021","journal-title":"Cell"},{"issue":"7409","key":"9792_CR147","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11243","volume":"488","author":"Y Shen","year":"2012","unstructured":"Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, Wagner U, Dixon J, Lee L, Lobanenkov VV, Ren B (2012) A map of the cis-regulatory sequences in the mouse genome. Nature 488(7409):116\u2013120. \nhttps:\/\/doi.org\/10.1038\/nature11243","journal-title":"Nature"},{"issue":"5950","key":"9792_CR148","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.1181369","volume":"326","author":"E Lieberman-Aiden","year":"2009","unstructured":"Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO, Sandstrom R, Bernstein B, Bender MA, Groudine M, Gnirke A, Stamatoyannopoulos J, Mirny LA, Lander ES, Dekker J (2009) Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326(5950):289\u2013293. \nhttps:\/\/doi.org\/10.1126\/science.1181369","journal-title":"Science"},{"issue":"8","key":"9792_CR149","doi-asserted-by":"publisher","first-page":"e1006985","DOI":"10.1371\/journal.pgen.1006985","volume":"13","author":"M Gomez-Velazquez","year":"2017","unstructured":"Gomez-Velazquez M, Badia-Careaga C, Lechuga-Vieco AV, Nieto-Arellano R, Tena JJ, Rollan I, Alvarez A, Torroja C, Caceres EF, Roy AR, Galjart N, Delgado-Olguin P, Sanchez-Cabo F, Enriquez JA, Gomez-Skarmeta JL, Manzanares M (2017) CTCF counter-regulates cardiomyocyte development and maturation programs in the embryonic heart. PLoS Genet 13(8):e1006985. \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1006985","journal-title":"PLoS Genet"},{"issue":"17","key":"9792_CR150","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.117.029430","volume":"136","author":"M Rosa-Garrido","year":"2017","unstructured":"Rosa-Garrido M, Chapski DJ, Schmitt AD, Kimball TH, Karbassi E, Monte E, Balderas E, Pellegrini M, Shih TT, Soehalim E, Liem D, Ping P, Galjart NJ, Ren S, Wang Y, Ren B, Vondriska TM (2017) High-resolution mapping of chromatin conformation in cardiac myocytes reveals structural remodeling of the epigenome in heart failure. Circulation 136(17):1613\u20131625. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029430","journal-title":"Circulation"},{"issue":"12","key":"9792_CR151","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nrg.2016.147","volume":"17","author":"B Bonev","year":"2016","unstructured":"Bonev B, Cavalli G (2016) Organization and function of the 3D genome. Nat Rev Genet 17(12):772. \nhttps:\/\/doi.org\/10.1038\/nrg.2016.147","journal-title":"Nat Rev Genet"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09792-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T06:10:46Z","timestamp":1591251046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09792-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,11]]},"references-count":151,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["9792"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09792-3","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,11]]},"assertion":[{"value":"11 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}